A detailed history of Royal Bank Of Canada transactions in Compass Pathways PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 119,343 shares of CMPS stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,343
Previous 53,477 123.17%
Holding current value
$1.02 Million
Previous $456,000 123.46%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
65,866 Added 123.17%
119,343 $1.02 Million
Q2 2024

Aug 14, 2024

BUY
N/A
8,270 Added 18.29%
53,477 $456,000
Q1 2024

Nov 05, 2024

SELL
N/A
-8,270 Reduced 15.46%
45,207 $386,000
Q1 2024

May 15, 2024

BUY
N/A
15,556 Added 52.46%
45,207 $386,000
Q4 2023

Feb 14, 2024

BUY
N/A
11,391 Added 62.38%
29,651 $253,000
Q3 2023

Nov 14, 2023

BUY
N/A
837 Added 4.8%
18,260 $155,000
Q2 2023

Aug 14, 2023

SELL
$7.79 - $10.69 $451 - $620
-58 Reduced 0.33%
17,423 $148,000
Q1 2023

May 15, 2023

BUY
$7.32 - $10.85 $24,961 - $36,998
3,410 Added 24.23%
17,481 $173,000
Q4 2022

Feb 14, 2023

BUY
$7.84 - $11.68 $4,508 - $6,716
575 Added 4.26%
14,071 $112,000
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $113,738 - $212,742
10,600 Added 366.02%
13,496 $145,000
Q2 2022

Aug 15, 2022

SELL
$6.76 - $14.18 $2,028 - $4,254
-300 Reduced 9.39%
2,896 $32,000
Q1 2022

May 16, 2022

SELL
$11.13 - $23.04 $33,278 - $68,889
-2,990 Reduced 48.33%
3,196 $41,000
Q4 2021

Feb 14, 2022

SELL
$21.81 - $48.96 $41,002 - $92,044
-1,880 Reduced 23.31%
6,186 $136,000
Q3 2021

Nov 15, 2021

BUY
$29.03 - $38.62 $41,164 - $54,763
1,418 Added 21.33%
8,066 $240,000
Q2 2021

Aug 16, 2021

BUY
$32.29 - $39.68 $214,663 - $263,792
6,648 New
6,648 $253,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.